Glenmark Pharmaceuticals today said it has received three observations from the US health regulator for its Pithampur, Indore plant. (Source: website) Glenmark Pharmaceuticals has entered into an ...

(Reuters) - Vectura Group said on Friday a British court had ruled in its favor on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline. Vectura said the court ...

(Alliance News) - Vectura Group PLC on Friday said the English High Court dismissed a case against Sandoz Ltd's generic version of GlaxsmithKline PLC's Seretide Accuhaler. The case was bought against ...

"Glenmark Pharmaceuticals Europe today has entered into a strategic development & licensing agreement with Celon Pharma SA to develop and market a generic version of GlaxoSmithKline's Seretide ...

Mumbai: Glenmark Pharmaceuticals Ltd said on Friday that it has received regulatory approval for the generic version of GlaxoSmithKline Plc’s Seretide Accuhaler in the Nordic region, which includes ...

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, announced today that its subsidiary Glenmark Arzneimittel GmbH has secured ...

Around 6,000 inhalers used by asthma patients have been recalled by health officials. Asthma UK said that ‘faulty inhalers could put people’s lives at risk’ as it called on patients to check whether ...

Glenmark Pharmaceuticals Europe Ltd has entered into a strategic development and licensing agreement with Celon Pharma SA to develop and market a generic version of GSK's Seretide Accuhaler product - ...

Glenmark Pharmaceuticals Europe Ltd has entered into a strategic development and licensing agreement with Celon Pharma SA to develop and market a generic version of GSK’s Seretide Accuhaler product — ...

Glenmark Pharmaceuticals has entered into an agreement with Poland based Celon Pharma to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler in Europe used for treatment of ...